5 news items
Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
1 Aug 24
results could differ materially from those described or implied by such forward-looking statements as a result of various factors, including, without
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
25 Jul 24
may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate Receptor-⍺ Targeted Topoisomerase I Inhibitor Antibody-Drug Conjugate
22 Jul 24
, but they are inherently uncertain. Zymeworks may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
17 Jun 24
, but they are inherently uncertain. Zymeworks may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially
Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer
10 Jun 24
, but they are inherently uncertain. Zymeworks may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from
- Prev
- 1
- Next